Peptide Science FOX04-DRI (Proxofim) 10mg

Peptide Science FOX04-DRI (Proxofim) is a synthetic peptide that belongs to a class of molecules known as senolytics. Senolytics are compounds that selectively target and eliminate senescent cells (cells that have stopped dividing and contribute to aging and age-related diseases). FOX04-DRI is designed to target and disrupt a specific protein complex, which is involved in maintaining the survival of senescent cells.

In particular, Proxofim (FOX04-DRI) targets the p53-dependent senescence pathway, which plays a key role in the growth arrest of senescent cells. By inhibiting this pathway, FOX04-DRI promotes the apoptosis (programmed cell death) of senescent cells, potentially reducing the harmful effects they have on tissue function, inflammation, and aging.

Key aspects of FOX04-DRI (Proxofim):

• Mechanism of Action: FOX04-DRI works by inhibiting the binding of the FOXO4 protein to p53, which results in the death of senescent cells.
• Potential Benefits: This peptide is being researched for its potential to improve tissue function, reduce inflammation, and possibly extend healthy lifespan by clearing harmful senescent cells.
• Application in Research: FOX04-DRI has primarily been studied in the context of aging, cellular senescence, and age-related diseases.